News

Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...
For patients newly diagnosed with atrial fibrillation (AF) during hospitalization for other causes, most are not dispensed ...
Dr. Paul Dorian, MD, CM, MSc., Cardiologist, discusses atrial fibrillation treatment options.
Dr. Paul Dorian, MD, CM, MSc., Cardiologist, discusses what happens to the heart when in atrial fibrillation.
The biomedical market’s latest technology for treating irregular heartbeats has made its way to the Flathead Valley, bringing ...
"Your heart has a rhythm of its own, until AFib crashes the party like an unwanted guest." writes Dr. Imdad Ahmed of ...
A recently completed clinical study investigated whether a toilet seat equipped with ECG sensors can reliably detect atrial fibrillation. The “Hamberger Heart Study” was conducted at the ...
In a subgroup of patients with atrial fibrillation, resuming anticoagulant therapy was associated with fewer long-term mortality (pooled RR 0.27, 95% CI 0.20 to 0.37, p<0.001). Conclusions Based on ...
You won’t die from vasovagal syncope on its own. However, the suddenness of the reaction and temporary loss of consciousness that follows can lead to dangerous falls and injuries. Vasovagal syncope ...
In patients with AF, abelacimab, compared with rivaroxaban, is associated with decreased bleeding across multiple bleeding risk categories. Abelacimab is associated with reduced bleeding compared ...